Baolingbao Biology Co.,Ltd. (SHE:002286)
China
· Delayed Price · Currency is CNY 10.17
-0.01 (-0.10%)
Apr 29, 2026, 3:04 PM CST
Baolingbao Biology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 3,870 | 3,402 | 2,729 | 3,011 | 3,380 | 5,028 | Upgrade
|
| Market Cap Growth | 33.34% | 24.68% | -9.36% | -10.92% | -32.78% | 19.45% | Upgrade
|
| Enterprise Value | 3,803 | 3,335 | 2,816 | 3,117 | 3,446 | 4,715 | Upgrade
|
| Last Close Price | 10.17 | 8.94 | 7.35 | 7.94 | 8.80 | 13.01 | Upgrade
|
| PE Ratio | 24.64 | 22.59 | 24.55 | 55.79 | 25.38 | 24.94 | Upgrade
|
| Forward PE | - | 46.25 | 46.25 | 46.25 | 46.25 | 46.25 | Upgrade
|
| PS Ratio | 1.38 | 1.24 | 1.14 | 1.19 | 1.25 | 1.82 | Upgrade
|
| PB Ratio | 1.68 | 1.52 | 1.34 | 1.52 | 1.69 | 2.77 | Upgrade
|
| P/TBV Ratio | 1.77 | 1.61 | 1.42 | 1.62 | 1.80 | 2.99 | Upgrade
|
| P/FCF Ratio | 68.35 | 48.56 | 46.42 | 23.15 | - | 44.33 | Upgrade
|
| P/OCF Ratio | 14.86 | 13.12 | 10.97 | 10.67 | 109.66 | 24.38 | Upgrade
|
| EV/Sales Ratio | 1.35 | 1.21 | 1.17 | 1.24 | 1.27 | 1.71 | Upgrade
|
| EV/EBITDA Ratio | 11.78 | 10.85 | 10.75 | 17.55 | 13.36 | 14.83 | Upgrade
|
| EV/EBIT Ratio | 18.97 | 17.66 | 19.60 | 52.14 | 22.01 | 22.14 | Upgrade
|
| EV/FCF Ratio | 67.15 | 47.59 | 47.90 | 23.97 | - | 41.58 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.05 | 0.14 | 0.15 | 0.26 | 0.23 | Upgrade
|
| Debt / EBITDA Ratio | 0.68 | 0.37 | 1.07 | 1.67 | 1.97 | 1.30 | Upgrade
|
| Debt / FCF Ratio | 3.84 | 1.65 | 4.81 | 2.34 | - | 3.63 | Upgrade
|
| Net Debt / Equity Ratio | -0.03 | -0.07 | 0.01 | 0.03 | 0.07 | -0.15 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.21 | -0.52 | 0.11 | 0.35 | 0.55 | -0.88 | Upgrade
|
| Net Debt / FCF Ratio | -1.20 | -2.30 | 0.47 | 0.47 | -0.63 | -2.47 | Upgrade
|
| Asset Turnover | 0.99 | 1.01 | 0.90 | 0.89 | 0.90 | 0.98 | Upgrade
|
| Inventory Turnover | 7.49 | 7.82 | 7.49 | 7.58 | 7.75 | 9.56 | Upgrade
|
| Quick Ratio | 1.11 | 1.17 | 0.88 | 0.87 | 0.83 | 0.89 | Upgrade
|
| Current Ratio | 1.79 | 1.89 | 1.41 | 1.36 | 1.31 | 1.17 | Upgrade
|
| Return on Equity (ROE) | 7.03% | 7.05% | 5.52% | 2.71% | 6.98% | 11.81% | Upgrade
|
| Return on Assets (ROA) | 4.38% | 4.33% | 3.37% | 1.32% | 3.24% | 4.72% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.81% | 7.72% | 5.92% | 2.37% | 7.24% | 12.54% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.50% | 8.20% | 6.80% | 2.90% | 7.00% | 11.20% | Upgrade
|
| Earnings Yield | 3.99% | 4.43% | 4.07% | 1.79% | 3.94% | 4.01% | Upgrade
|
| FCF Yield | 1.46% | 2.06% | 2.15% | 4.32% | -6.62% | 2.26% | Upgrade
|
| Dividend Yield | 1.18% | - | 1.29% | 1.01% | 0.91% | 0.46% | Upgrade
|
| Payout Ratio | 19.93% | 21.20% | 49.76% | 92.20% | 39.43% | 19.32% | Upgrade
|
| Buyback Yield / Dilution | -2.80% | 0.85% | -2.99% | 2.74% | 0.91% | -4.81% | Upgrade
|
| Total Shareholder Return | -1.64% | 0.85% | -1.69% | 3.74% | 1.81% | -4.35% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.